CollPlant Biotechnologies
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4 Oppenheimer Weizmann Science Park, Reh...Phone Number
+972 732325600Website
www.collplant.comRevenue
<$5 MillionStock Symbol
CLGNIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About CollPlant Biotechnologies
CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. The company's products are based on the company's rhCollagen (recombinant human collagen) that is produced with CollPlant's proprietary plant based genetic engineering technology. The company's products address indications for the diverse fields of tissue repair, aesthetics and organ manufacturing, and, the company believes, are ushering in a new era in regenerative and aesthetic medicine. The company's flagship rhCollagen BioInk product line is ideal for 3D bioprinting of tissues and organs. In October 2018, the company entered into a licensing agreement with United Therapeutics, whereby United Therapeutics is using CollPlant's BioInks in the manufacture of 3D bioprinted lungs for transplant in humans.Explore more
CollPlant Biotechnologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CollPlant Biotechnologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if CollPlant Biotechnologies had a recent Job posting/layoffs
Product Launch: Get notified when CollPlant Biotechnologies launches new products
Congratulate Masked Content for being promoted to Masked Content at CollPlant Biotechnologies
Check if CollPlant Biotechnologies has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on CollPlant Biotechnologies recently announced quarterly report
Check out if CollPlant Biotechnologies is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once CollPlant Biotechnologies has new funding data
CollPlant Biotechnologies, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined CollPlant Biotechnologies as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
CollPlant Biotechnologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CollPlant Biotechnologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CollPlant Biotechnologies.
CollPlant Biotechnologies financials insights
Gather financial insights about CollPlant Biotechnologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$4.5M
2026
Private Equity
$4M
CollPlant Biotechnologies Tech Stack
A closer look at the technologies used by CollPlant Biotechnologies
See more technologies
Most Recent Scoops
Funding
Funding
Earnings
CollPlant Biotechnologies has recently released 2024 Q1 report with the following insight: Competition is intense in the dermal filler and breast implant markets from major players. Regulatory approval is inherently risky and clinical failures could occur. An economic downturn could make raising more capital challenging.
Earnings
CollPlant Biotechnologies has recently released 2024 Q1 report with the following insight: CollPlant is focused on developing regenerative medicine products using its proprietary collagen technology. The company sees significant growth opportunities in the market for dermal fillers and breast implants.
Earnings
CollPlant Biotechnologies has recently released 2024 Q1 report with the following insight: CollPlant has launched sustainability/ESG initiatives to reduce its carbon footprint and released its first ESG report. This could help attract interest from investors and partners.
Earnings
CollPlant Biotechnologies News & Media
COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
REHOVOT, Israel, May 29, 2026 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and medical aesthetics company developing innovative technologies and products based on its non-animal-derived recombinant human collagen (rhCollagen) for tissue regeneration and medical...CollPlant Issues Letter to Shareholders
REHOVOT, Israel, April 13, 2026 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary plant-derived recombinant human collagen (rhCollagen), is pleased to issue the following letter...COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
REHOVOT, Israel, March 26, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived rhCollagen for tissue regeneration and medical aesthetics, today...CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
REHOVOT, Israel, March 24, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary recombinant human collagen (rhCollagen) platform, today announced that on March...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CollPlant Biotechnologies
Sign Up For FreeTo access detailed company insights
CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. The company's products are based on the company's rhCollagen (recombinant human collagen) that is produced with CollPlant's proprietary plant based genetic engineering technology. The company's products address indicat... Read More
